Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Dissociative / Memantine
Dissociative

Memantine

3,5-dimethyladamantan-1-amine

Memantine is an FDA-approved prescription medication for moderate-to-severe Alzheimer's disease; it is an NMDA-receptor antagonist with low abuse potential, included here for context alongside the dissociatives it is chemically related to.

Overview

Memantine is a prescription medication approved by the U.S. Food and Drug Administration to treat moderate-to-severe Alzheimer's disease. It is sold as a tablet, an extended-release capsule, and an oral solution, and is often prescribed together with a different class of Alzheimer's drug (cholinesterase inhibitors such as donepezil). Memantine does not cure Alzheimer's disease; it can help moderate symptoms and slow some of the decline associated with it. It is included in this library mainly for context: memantine acts on the same NMDA-receptor system as dissociative drugs like ketamine and PCP, but it is a legitimate, well-tolerated medicine with low potential for misuse, which makes it a useful point of comparison rather than a recreational substance.

Source: MedlinePlus; FDA; NIH (StatPearls)

Chemistry & mechanism of action

Memantine is a low-affinity, uncompetitive NMDA-receptor antagonist. In Alzheimer's disease, excessive activity of the neurotransmitter glutamate at NMDA receptors is thought to contribute to ongoing nerve-cell damage. Memantine partially blocks these receptors in a way that dampens harmful overactivation while still allowing the normal signaling needed for memory and learning — a 'gentler' block than strong dissociatives produce. This is why memantine, despite sharing a receptor target with ketamine and PCP, does not produce the same intense dissociative state at therapeutic doses.

Source: NIH (StatPearls); peer-reviewed pharmacology literature

Effects

Taken as prescribed, memantine is generally well tolerated. The most common side effects include dizziness, headache, confusion, and constipation. Because it acts gradually and at controlled doses, it does not produce the euphoria or dissociative 'high' associated with recreational NMDA-blocking drugs, and it is not typically sought out for misuse. As with any medication, effects and tolerability vary between individuals, and it should be taken only as directed by a prescriber.

Source: MedlinePlus; FDA

Risks & harms

Memantine has a comparatively favorable safety profile when used as prescribed, and a low potential for abuse relative to other drugs in the dissociative family. Side effects are usually mild, but higher-than-prescribed doses or combination with other medicines can cause problems, and people with certain kidney conditions may need dose adjustments. As a prescription medication it should be taken only under medical supervision and not shared with others. If an overdose is suspected, contact Poison Control at 1-800-222-1222, or call 911 in an emergency. Anyone with questions about memantine should speak with their prescriber or pharmacist.

Source: MedlinePlus; FDA

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With dissociatives, coordination and judgment are impaired and effects can come in waves, sit or lie down somewhere safe so you don't fall, and don't drive or make decisions until it clears.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown, pending review”

Identity

IUPAC name
3,5-dimethyladamantan-1-aminePubChem PUG-REST ↗ · retrieved 2026-06-18
SMILES
CC12CC3CC(C1)(CC(C3)(C2)N)CPubChem PUG-REST ↗ · retrieved 2026-06-18
InChIKey
BUGYDGFZZOZRHP-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
Synonyms / aliases
namenda, 3,5-dimethyladamantan-1-amine, 1-Amino-3,5-dimethyladamantane, Memantina, 3,5-Dimethyl-1-adamantanamine, Memantinum, 1,3-Dimethyl-5-adamantanamine, nemdatine, 3,5-Dimethyl-1-aminoadamantane, 1,3-Dimethyl-5-aminoadamantane, MemantinPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
3 DOSAGE FORMS AND STRENGTHS Memantine Hydrochloride Tablet USP, 5 mg: orange colored, oblong, biconvex, film-coated tablets debossed “IP 173” on one side and popenFDA drug label ↗ · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown, pending review

Effects, risks & interactions

Effects
Memantine is a prescription medicine rather than a recreational drug: it is an NMDA-receptor antagonist approved to treat the symptoms of moderate-to-severe Alzheimer's disease, where it is thought to help by dampening the excessive glutamate signalling that can damage nerve cells. At therapeutic doses it is not intoxicating; unlike the dissociative anaesthetics in this class it is designed for steady daily use and does not produce their acute "dissociative" high. What people notice during treatment relates to its side-effect profile rather than to any sought-after effect.MedlinePlus Memantine + PubChem CID 4054 ↗ · retrieved 2026-06-18
Risks
As a medicine, memantine's risks are framed as side effects and cautions. Reported adverse effects include dizziness, headache, confusion and constipation and, less commonly, drowsiness or hallucinations. It needs careful use in people with kidney impairment, which slows how the body clears it, and in certain urinary conditions. Because it is an NMDA antagonist, any attempt to misuse it for a dissociative effect would require far more than the therapeutic amount and risks confusion, agitation and other central-nervous-system effects. As with any prescription medicine, it should be taken only as directed by a clinician.MedlinePlus Memantine + PubChem CID 4054 ↗ · retrieved 2026-06-18
Interactions
Memantine's approved labelling flags two interaction concerns. Drugs and conditions that make the urine more alkaline — for example carbonic-anhydrase inhibitors or sodium bicarbonate — can substantially reduce how quickly the body clears memantine, allowing it to build up and raising the chance of adverse effects. The label also states that combining memantine with other NMDA-receptor antagonists — amantadine, ketamine and dextromethorphan — has not been systematically studied and should be approached with caution.DailyMed Memantine §7 Drug Interactions ↗ · retrieved 2026-06-18

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 130different versions. Make sure you’re looking at the right one, use the search above to find your exact pill by imprint, color, or shape.

Showing 24 of 130 variants

?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Aphena Pharma Solutions - Tennessee, LLC
NDC
71610-011 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
NorthStar RxLLC
NDC
72603-118 ↗ · 2026-06-18
RDY 597
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 10 mg/1
Imprint
RDY 597
Color
GRAY
Shape
CAPSULE
Form
TABLET
Labeler
NorthStar RxLLC
NDC
72603-119 ↗ · 2026-06-18
R 854
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 21 mg/1
Imprint
R 854
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rising Pharma Holdings, Inc.
NDC
16571-854 ↗ · 2026-06-18
211
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
211
Color
ORANGE
Shape
CAPSULE
Form
TABLET, COATED
Labeler
Alembic Pharmaceuticals Inc.
NDC
62332-075 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
Aphena Pharma Solutions - Tennessee, LLC
NDC
71610-979 ↗ · 2026-06-18
R 855
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 28 mg/1
Imprint
R 855
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rising Pharma Holdings, Inc.
NDC
16571-855 ↗ · 2026-06-18
L212
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 10 mg/1
Imprint
L212
Color
GRAY
Shape
CAPSULE
Form
TABLET, COATED
Labeler
Alembic Pharmaceuticals Inc.
NDC
62332-076 ↗ · 2026-06-18
AN 1247
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
DONEPEZIL HYDROCHLORIDE 10 mg/1; MEMANTINE HYDROCHLORIDE 28 mg/1
Imprint
AN 1247
Color
yellow
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals NY LLC
NDC
69238-1247 ↗ · 2026-06-18
CL 27
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
CL 27
Color
PINK
Shape
CAPSULE
Form
TABLET
Labeler
Macleods Pharmaceuticals Limited
NDC
33342-297 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 7 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Major Pharmaceuticals
NDC
0904-6734 ↗ · 2026-06-18
CL 28
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 10 mg/1
Imprint
CL 28
Color
GRAY
Shape
CAPSULE
Form
TABLET
Labeler
Macleods Pharmaceuticals Limited
NDC
33342-298 ↗ · 2026-06-18
AN 1248
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
DONEPEZIL HYDROCHLORIDE 10 mg/1; MEMANTINE HYDROCHLORIDE 14 mg/1
Imprint
AN 1248
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals NY LLC
NDC
69238-1248 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 28 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Major Pharmaceuticals
NDC
0904-6735 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
REMEDYREPACK INC.
NDC
70518-3338 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
NDC
0615-8319 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
NDC
71335-2013 ↗ · 2026-06-18
184
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
DONEPEZIL HYDROCHLORIDE 10 mg/1; MEMANTINE HYDROCHLORIDE 14 mg/1
Imprint
184
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Macleods Pharmaceuticals Limited
NDC
33342-312 ↗ · 2026-06-18
185
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
DONEPEZIL HYDROCHLORIDE 10 mg/1; MEMANTINE HYDROCHLORIDE 28 mg/1
Imprint
185
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Macleods Pharmaceuticals Limited
NDC
33342-313 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
NDC
71335-1732 ↗ · 2026-06-18
AN 785
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 28 mg/1
Imprint
AN 785
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals LLC
NDC
65162-785 ↗ · 2026-06-18
AN 782
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 7 mg/1
Imprint
AN 782
Color
yellow
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals LLC
NDC
65162-782 ↗ · 2026-06-18
AN 783
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 14 mg/1
Imprint
AN 783
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals LLC
NDC
65162-783 ↗ · 2026-06-18
AN 784
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
MEMANTINE HYDROCHLORIDE 21 mg/1
Imprint
AN 784
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Amneal Pharmaceuticals LLC
NDC
65162-784 ↗ · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index